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RESEARCH ARTICLE
The relationship between microvascular complications and depression in patients with 
type 2 diabetes mellitus who use insulin
İnsülin kullanan tip 2 diabetes mellitus hastalarında mikrovasküler komplikasyonlar ile 
depresyonun ilişkisi
Mehmet Ali Eren1, Ayşe Nur Torun1, Suzan Tabur1, Muharrem İngeç2, Mehmet Demir2,
Tevfik Sabuncu1, İbrahim Fatih Karababa3
ÖZET
Amaç: Bu çalışmada kronik bir hastalık olan Tip 2 Dia-
betes  Mellitus  (DM)  ve  komplikasyonlarının  depresyon 
şiddeti ile ilişkisi değerlendirilmesi amaçlandı.
Yöntemler: Çalışmaya 65 yaşından küçük, insülin kullan-
makta olan 80 Tip 2 DM hastası alınarak klinik ve biyokim-
yasal verileri kaydedildi. Nöropati şiddeti “United Kingdom 
nöropati tarama skoru” (UKNS) ile, depresyon şiddeti ise 
“Beck Depresyon Envanteri” (BDE) ile belirlendi. Nefro-
pati spot idrar örneğinde mikroalbumin-kreatinin oranı ile, 
retinopati ise göz dibi muayenesi ile değerlendirildi.
Bulgular: Beck depresyon şiddeti yüksek olan hasta gru-
bu içindeki nöropati şiddeti yüksek olan hasta sayısı daha 
fazlaydı  (p<0,001).  Korelasyon  analizinde  BDE  şiddeti 
ile UKNS arasında pozitif korelasyon saptandı (r=0,231, 
p=0,039).  Nefropati  ve  retinopati  ile  depresyon  şiddeti 
arasında bir ilişki bulunmadı.
Sonuç: Çalışmamızda nöropati şiddeti ile depresyon şid-
deti arasında anlamlı bir ilişki vardı. Bu nedenle Tip 2 DM 
tanısı olan olgular nöropati ve depresyon varlığı açısın-
dan taranmalıdır. Eşlik eden bu durumlara yönelik uygun 
yaklaşımlar  hayat  kalitesini  arttırmak  açısından  önemli 
olabilir.
Anahtar kelimeler:  Tip  2  Diabetes  Mellitus,  nöropati, 
nefropati, retinopati, depresyon
ABSTRACT
Objective: This study aimed to assess the relationship 
between Type 2 Diabetes Mellitus (DM) and its complica-
tions with the severity of depression.
Methods:  Eighty  diabetics  under  the  age  of  65  using 
insulin were enrolled and clinical and biochemical data 
were  recorded. The  severity  of  neuropathy  was  deter-
mined  by  the  “United  Kingdom  neuropathy  screening 
score” (UKNS) whereas the severity of depression was 
determined by the “Beck depression scale” (BDS). Ne-
phropathy and retinopathy were assessed by the micro-
albumin-creatinine ratio in spot urine samples and by de-
tailed examination of the retina with an ophthalmoscope, 
respectively.
Results: There were more patients who has high neurop-
athy severity in the group with the highest Beck depres-
sion scale score (p<0.001). In the correlation analyses, 
positive  correlation  was  found  between  the  severity  of 
depression determined by the BDS and UKNS (r=0.231, 
p=0.039). No relationship was found between nephropa-
thy, retinopathy and severity of depression. 
Conclusion: There was significant relationship between 
the severity of neuropathy and that of depression. Hence, 
cases with a diagnosis of Type 2 DM require screening in 
terms of neuropathy and the presence of depression. Ap-
propriate approach towards such conditions associated 
with each other may be crucial in the context of increasing 
the quality of life. J Clin Exp Invest 2013; 4 (1): 34-39
Key words: Type 2 Diabetes Mellitus; neuropathy, ne-
phropathy; retinopathy; depressionEren et al. Microvascular complications and depression in type 2 diabetes mellitus 35
J Clin Exp Invest   www.jceionline.org   Vol 4, No 1, March 2013
INTRODUCTION
Type 2 Diabetes Mellitus (DM) is a chronic and pro-
gressive disease during which microvascular com-
plications  such  as  nephropathy,  neuropathy  and 
retinopathy may develop.1,2 As is the case in other 
chronic diseases, the frequency of anxiety and de-
pression increases in Type 2 DM.3,4
Depression, first in line among diseases most 
frequently associated with Type 2 DM, has been re-
ported to disrupt the glycemic control, and recovery 
from  hyperglycemia,  improvement  in  depression 
symptoms.5-7 The presence of depression is thought 
to complicate the glycemic control by disrupting the 
harmony between diet, exercise and therapy.8 Be-
sides studies suggesting a correlation between the 
level of HbA1c, a good marker of glycemic control, 
and depressive symptoms, there are some which 
point to the contrary.9
In our study, we investigated the impact of dia-
betic microvascular complications on the frequency 
and severity of depression in Type 2 DM cases.
METHODS
Cases under the age of 65 admitted to our Endocri-
nology clinic, which had been using insulin for the 
past 6 months and/or more, were enrolled in this 
study. The study was approved by Harran Univer-
sity ethics committee. After informing patients about 
the study, their verbal and written consents were 
collected. Patients who had been diagnosed with 
depression or those who received anti-depressant 
therapy  within  the  past  6  months  were  excluded 
from  the  study.  For  the  determination  of  diabetic 
nephropathy, the spot urine albumin-creatinine ra-
tio was measured in the first morning urine. Cases 
with a serum creatinine level of >1.4 mg/dl were ex-
cluded from the study. Detailed examination of the 
retina with an ophthalmoscope was performed for 
the determination of diabetic retinopathy. The pres-
ence and severity of diabetic neuropathy was de-
fined by the “United Kingdom neuropathy screening 
score” (UKNS) as normal, mild, moderate and se-
vere. The severity of the depression symptoms was 
assessed  by  the  “Beck  depression  scale”  (BDS). 
Patients were divided into four groups according to 
the severity of their depression determined by the 
Beck depression scale (total score=63 points), and 
hence group 1, 2, 3 and 4 were defined as minimal 
(0-9 points), mild (10-16 points), moderate (17-29 
points) and severe (30-63 points), respectively.
Statistical analysis
SPSS version 15.0 (Windows, Chicago, IL, USA) 
was used for statistical analyses. Results were giv-
en as average ± standard deviation (SD). Categori-
cal variants were compared via the Chi-squared test 
whereas the continuous variants were compared via 
the unpaired Student’s t or Mann-Whitney U tests 
according to their compatibility with normal distribu-
tion. One-way ANOVA was used for the comparison 
between  parametric  data  between  three  or  more 
groups, and the Turkey test was used as the post 
hoc test. In the comparison between three or more 
groups, Kruskal-Wallis variation analysis was used 
along with the Mann-Whitney U test for sub group 
comparisons  of  the  obtained  results.  Spearman 
correlation  test  was  used  in  correlation  analysis. 
p<0.05 was considered to be statistically significant.
RESULTS
An overall number of 80 Type 2 DM patients were 
included in the study. The groups were found to be 
biochemically  similar  (Table  1  and  Table  2).  De-
pression severity determined by the BDS showed 
significant increase going from group 1 to group 4 
(p<0.001 between all groups). Furthermore, as go-
ing from group 1 to group 4 according to the UKNS, 
there was an increase in the ratio of patients with 
moderate neuropathy (8.3% for group 2, 26% for 
group 3, 8.3% for group 4) or in the ratio of pa-
tients with severe neuropathy (4.2% for group 2 and 
33.3% for group 4) (p<0.001). In the Spearman cor-
relation analysis, there was a positive correlation 
between the severity of the depression determined 
by the BDS and triglyceride (TG) (r=0.235, p=0.036) 
and the UKNS (r=0.231, p=0.039) (Figure 1, Figure 
2). No correlation was found between the presence 
of retinopathy and nephropathy and the severity of 
the depression (Table 3).Eren et al. Microvascular complications and depression in type 2 diabetes mellitus 36
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Table 1. A comparison of clinical data between groups (*p<0.001 between all groups).
Group 1
 (n=14)
Group 2
 (n=24)
Group 3
 (n=30)
Group 4
 (n=12)
Age (years) 48.3±14.0 51.3±10.0 51.2±8.1 48.3±10.4
BMI (kg/m2) 28.9±4.8 28.6±3.9 30.1±4.9 31.5±10.6
BECK* 8.0±0.7 12.0±1.9 23.9±3.7 33.2±3.8
Gender (M/F) 7/7 9/15 8/22 2/10
History of smoking (Yes/No) 7/7 6/18 8/22 3/9
History of drinking (Yes/No) 0/14 0/24 0/30 0/12
Marital status
Married 13 23 30 11
Single 1 0 0 0
Divorced/Widower  0 1 0 1
Retinopathy (Yes/No) 3/11 6/18 8/22 5/7
History of depression (Yes/No) 4/10 2/22 7/23 5/7
Neuropathy (Yes/No) 4/10 3/21 9/21 5/7
UKNS*
None 10 21 21 7
Mild 4 0 1 0
Moderate 0 2 8 1
Severe 0 1 0 4
UKNS: United Kingdom neuropathy screening score
UKNS: United Kingdom neuropathy screening score, BMI: Body mass index
Table 2. A comparison of biochemical data between groups* (*p>0.05 for all data).
Group 1
 (n=14)
Group 2
 (n=24)
Group 3
 (n=30)
Group 4
 (n=12)
Glucose (mg/dl) 347.2±119.9 284.6±129.2 294.4±116.3 276.3±113.7
Creatinin (mg/dl) 1.0±0.3 0.9±0.3 0.8±0.3 0.8±0.3
TCHOL (mg/dl) 173.6±40.0 182.1±59.6 213.0±74.6 189.9±44.6
LDL-C (mg/dl) 98.8±33.6 97.7±32.5 110.9±34.7 103.3±37.9
HDL-C (mg/dl) 35.8±9.6 37.2±3.0 35.5±8.0 34.1±13.5
TG (mg/dl) 217.0±207.3 259.3±157.1 276.0±169.4 271.3±94.1
Albumin (g/dl) 3.5±0.7 3.5±0.9 3.6±0.6 3.4±0.8
HbA1c (%) 10.8±3.0 10.4±2.3 11.1±1.4 11.5±2.7
ACR (µg/mg)  268.8±365.7 149.6±246.0 198.0±289.0 149.2±337.8
HbA1c: Glucosilated hemoglobin, HDL-C: High density lipoprotein cholesterol, LDL-C: Low density lipoprotein choles-
terol, ACR: Urine albumin-creatinin ratio, TG: Triglyceride, TCHOL: Total cholesterolEren et al. Microvascular complications and depression in type 2 diabetes mellitus 37
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Table 3.  A  correlation  between  the  Beck  depression 
severity and clinical and biochemical data 
r p
Age (years) 0.010 0.933
BMI (kg/m2) 0.92 0.419
Fasting Glucose (mg/dl) -0.185 0.101
TCHOL (mg/dl) 0.174 0.122
LDL-C (mg/dl) 0.124 0.292
HDL-C (mg/dl) 0.012 0.918
TG (mg/dl) 0.235 0.036
HbA1c (%) 0.121 0.287
ACR (µg/mg) -0.049 0.664
UKNS 0.231 0.039
HbA1c:  Glucosilated  hemoglobin,  HDL-C:  High  density 
lipoprotein  cholesterol,  LDL-C:  Low  density  lipoprotein 
cholesterol,  ACR:  Urine  albumin-creatinin  ratio,  TG: 
Triglyceride,  TCHOL:  Total  cholesterol,  UKNS:  United 
Kingdom neuropathy screening score, BMI: Body mass index
DISCUSSION
Chronic diseases generally lead to anxiety and de-
pression due to the fear of the future, of organ loss 
and  of  death.  The  symptoms  of  the  chronic  and 
progressive disease Type 2 DM frequently yield de-
pression because of emerging organ function loss 
and complications, disrupted quality of life and sec-
ondary biological changes to brain disease.10 The 
frequency of life-long depression in diabetic cases 
has raised two fold in comparison with the healthy 
control group.8 Moreover, depression is associated 
with  behavior  such  as  the  habit  of  smoking,  and 
weight  gain  rooting  from  lack  of  physical  activity 
and inappropriate food intake, hence, may cause 
obesity and impaired glucose tolerance followed by 
organ defects.8,11
It is well known that the frequency of depres-
sion increases in cases with diabetes-related com-
plications.12 In our study, the severity of depression 
symptoms and that of neuropathy were rising pro-
portionally whereas no evidence was found to the 
significant  correlation  between  depression  sever-
ity and the presence of retinopathy and nephropa-
thy. The relationship between diabetic neuropathy 
and the presence of depression has been shown 
in a number of studies.13-16 However, the number 
of  studies  investigating  the  relationship  between 
depression  symptoms  and  neuropathy  is  limited. 
Even though several systems were used in the as-
sessment  of  depression  severity  until  today,  the 
UKNS was reported to be a realistic, objective and 
accurate scoring system for the assessment of dia-
betic peripheral neuropathy.17 Therefore, the use of 
UKNS in our study seems like quite a valid assess-
ment method, and accordingly, there is a significant 
relationship between the UKNS. This finding sup-
ports the previous study results obtained by other 
scoring systems used for the determination of neu-
ropathy  severity  and  pointing  out  proportional  in-
crease in depression severity linked to neuropathy 
severity.18,19
Figure 1.  A  correlation  between 
the Beck depression severity and 
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Figure 2.  A  correlation  between 
the Beck depression severity and 
the UKNS.
We were not able to detect evident relationship 
between depression severity and TG. Lipid param-
eters, especially the relationship between low den-
sity lipoprotein cholesterol (LDL-C) and depression, 
were investigated in various patient groups, how-
ever, conflicting results were obtained.20-22 Heckbert 
et al. did not able to find any correlation between 
depression and LDL-C; whereas, Gary et al. neither 
found any correlation between depression and LDL-
C however defined significant relationship between 
depression and TG.23,24 In another study, TG was 
found to be higher in patients with associated cardi-
ac disease among Type 2 cases with major depres-
sion.25 As we did not perform sub group analyses 
in terms of cardiac diseases on our study patients, 
it does not seem possible to comment on such a 
correlation. On the other hand, one study showed 
that increase in TG levels leads to neuropathy in-
dependent of age, duration of disease and glycemic 
control.26 In the light of the current data, even if TG 
levels were not found to be so high, this increase 
may augment the severity of diabetic neuropathy, 
and this may be clinically vital for the approach to-
wards neuropathy.
Though the impact of dyslipidemia on the se-
verity of neuropathy has been evaluated in various 
studies, the mechanism of action of dyslipidemia-
dependent neuropathy is not yet clarified. As is well 
known, oxidative stress increases with Type 2 DM, 
and this leads to oxidation of various vital molecules 
containing lipids.27 It is advocated that the severity 
of diabetic neuropathy is related to these oxidized 
lipids.28
In  conclusion,  severity  of  depression  increases 
along with that of neuropathy in diabetic patients. 
There is a relationship between TG levels and de-
pression in diabetic patients. Due to these facts, the 
presence of neuropathy and depression might be 
investigated in diabetic patients especially with oth-
er micro vascular complications. The presentation 
of appropriate approach towards these associated 
conditions may have a positive effect on the pa-
tients’ quality of life. It is also possible that treatment 
of hyperlipidemia cause decrease in the severity of 
neuropathy and hence contribute to the treatment 
of depression.
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